Evidence map›Paper›PMID 35566343›Full record

ReviewMolecules (Basel, Switzerland)2022

The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance.

Bruno S Lopes, Alfizah Hanafiah, Ramesh Nachimuthu, Saravanan Muthupandian, Zarith Nameyrra Md Nesran, Sandip Patil

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 67 citations in OpenAlex.

  1. Antimicrobial Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Antimicrobial Resistance: The Answers.British journal of biomedical science · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. CombatingFrontiers in cellular and infection microbiology · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Bruno S LopesDepartment of Medical Microbiology, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Alfizah HanafiahDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.ORCID 0000-0003-4859-1439
Ramesh NachimuthuAntibiotic Resistance and Phage Therapy Laboratory, Department of Biomedical Sciences, Vellore Institute of Technology, School of Bioscience and Technology, Vellore 632014, India.
Saravanan MuthupandianAMR and Nanotherapeutics Laboratory, Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Chennai 600077, India.ORCID 0000-0002-1480-3555
Zarith Nameyrra Md NesranDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Sandip PatilDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518038, China.ORCID 0000-0003-2736-9206
National University of Malaysia · MYSaveetha University · INShenzhen Children's Hospital · CNUniversity of Aberdeen · GBVellore Institute of Technology University · IN

Funding

Ministry of Higher Education of Malaysia FRGS/1/2019/SKK11/UKM/02/3
6 · The paper itself

Abstract

Just over a million people died globally in 2019 due to antibiotic resistance caused by ESKAPE pathogens (

Indexed as

Anti-Infective AgentsEnterococcus faeciumAnti-Bacterial AgentsAntimicrobial PeptidesBiofilmsDrug Resistance, BacterialHumansMicrobial Sensitivity TestsPandemicsAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Peptidesantimicrobial peptidesantimicrobial resistancebiofilmsESKAPEGram-negative bacteriapublic healthWHO priority pathogens

Identifiers

PMID35566343
PMCPMC9105241
OpenAlexW4229373441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.